Literature DB >> 6999649

Thoracic outlet syndrome.

F A Crawford.   

Abstract

Thoracic outlet syndrome includes a variety of previously described syndromes, the common factor being compression of the neurovascular bundle as it exists from the thoracic outlet. Diagnosis is largely one of exclusion but may be aided in some patients by angiography, assessment of the conduction velocity of the ulnar nerve, and other objective tests. Many patients can improve with conservative treatment, but in those requiring surgery, the best results have been obtained with first rib resection. Currently, the most popular approach is transaxillary, and more than 90 per cent of patients with thoracic outlet syndrome will be relieved by this procedure.

Entities:  

Mesh:

Year:  1980        PMID: 6999649     DOI: 10.1016/s0039-6109(16)42193-6

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  6 in total

1.  Neurosurgery-epitomes of progress: paresthesias in the hands.

Authors:  J B Golden
Journal:  West J Med       Date:  1982-03

2.  Two-surgeon approach to thoracic outlet syndrome: long-term outcome.

Authors:  D Sharan; A Moulton; G H Greatrex; S K Das; A M Whiteley; V M Srivastava
Journal:  J R Soc Med       Date:  1999-05       Impact factor: 5.344

3.  Bilateral rudimentary first ribs as a cause of thoracic outlet syndrome.

Authors:  T Nguyen; F Baumgartner; B Nelems
Journal:  J Natl Med Assoc       Date:  1997-01       Impact factor: 1.798

4.  Exercise rehabilitation for neurogenic thoracic outlet syndrome: a scoping review.

Authors:  Derick Luu; Richard Seto; Kevin Deoraj
Journal:  J Can Chiropr Assoc       Date:  2022-04

5.  The enigma of neurogenic thoracic outlet syndrome following motor vehicle collisions.

Authors:  A Ian Munro; G Duncan McPherson
Journal:  Can J Surg       Date:  2016-08       Impact factor: 2.089

6.  Vascular compression in thoracic outlet syndrome--a potentially missed diagnosis.

Authors:  D S Grant; P J Shaw; M Adiseshia
Journal:  J R Soc Med       Date:  1988-08       Impact factor: 18.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.